PMC:7195088 / 6500-6862 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"157","span":{"begin":224,"end":232},"obj":"Species"},{"id":"184","span":{"begin":51,"end":60},"obj":"Species"},{"id":"197","span":{"begin":81,"end":111},"obj":"Chemical"},{"id":"198","span":{"begin":164,"end":182},"obj":"Chemical"},{"id":"217","span":{"begin":238,"end":246},"obj":"Disease"}],"attributes":[{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"Tax:9606"},{"id":"A184","pred":"tao:has_database_id","subj":"184","obj":"Tax:11520"},{"id":"A198","pred":"tao:has_database_id","subj":"198","obj":"MESH:D006886"},{"id":"A217","pred":"tao:has_database_id","subj":"217","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ly in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients with COVID-19 only if no important drug interactions can be anticipated and with close monitoring of hepatic, renal function and "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":51,"end":60},"obj":"Disease"},{"id":"T27","span":{"begin":238,"end":246},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ly in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients with COVID-19 only if no important drug interactions can be anticipated and with close monitoring of hepatic, renal function and "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T26","span":{"begin":81,"end":92},"obj":"Chemical"},{"id":"T27","span":{"begin":93,"end":111},"obj":"Chemical"},{"id":"T28","span":{"begin":164,"end":182},"obj":"Chemical"},{"id":"T29","span":{"begin":268,"end":272},"obj":"Chemical"}],"attributes":[{"id":"A26","pred":"chebi_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_5801"},{"id":"A29","pred":"chebi_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"ly in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients with COVID-19 only if no important drug interactions can be anticipated and with close monitoring of hepatic, renal function and "}

{"project":"LitCovid-sentences","denotations":[{"id":"T46","span":{"begin":62,"end":73},"obj":"Sentence"},{"id":"T47","span":{"begin":74,"end":128},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ly in the presence of suspected/proven concomitant influenza.\nQuestion 3. Should chloroquine/hydroxychloroquine be administered? Pending results of RCT, the use of hydroxychloroquine may be considered for treating worsening patients with COVID-19 only if no important drug interactions can be anticipated and with close monitoring of hepatic, renal function and "}